Avapritinib
Brand name: Ayvakyt
Avapritinib comes in 9 pill versions in our database, in 5 strengths, from 1 manufacturer. Check the imprint to tell them apart.
Avapritinib pill images
25 mg 2 pills
- BLU 25 Avapritinib 25 mg White, round, 5 mm Used for gastrointestinal stromal tumors
- No picture yet DIN 02551764 Avapritinib 25 mg Ayvakyt, Tablet, sold in Canada Used for gastrointestinal stromal tumors
50 mg 2 pills
- BLU 50 Avapritinib 50 mg White, round, 6 mm Used for gastrointestinal stromal tumors
- No picture yet DIN 02551772 Avapritinib 50 mg Ayvakyt, Tablet, sold in Canada Used for gastrointestinal stromal tumors
100 mg 2 pills
- BLU 100 Avapritinib 100 mg White, round, 9 mm Used for gastrointestinal stromal tumors
- BLU 100 Avapritinib 100 mg White, round Used for gastrointestinal stromal tumors
200 mg 2 pills
- BLU 200 Avapritinib 200 mg White, capsule, 16 mm Used for gastrointestinal stromal tumors
- BLU 200 Avapritinib 200 mg White, capsule Used for gastrointestinal stromal tumors
300 mg 1 pill
What is Avapritinib used for?
Avapritinib is used for gastrointestinal stromal tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
PDGFRA Exon 18 Mutation-Positive Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
AYVAKIT® is indicated for the treatment of adults with unresectable or metastatic GIST harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations.
Advanced Systemic Mastocytosis (AdvSM)
AYVAKIT is indicated for the treatment of adult patients with advanced systemic mastocytosis (AdvSM). AdvSM includes patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL).
Limitations of Use:
AYVAKIT is not recommended for the treatment of patients with AdvSM with platelet counts of less than 50 × 109/L.
Indolent Systemic Mastocytosis (ISM)
AYVAKIT is indicated for the treatment of adult patients with indolent systemic mastocytosis (ISM).
Limitations of Use:
AYVAKIT is not recommended for the treatment of patients with ISM with platelet counts of less than 50 × 109/L.
From the FDA-approved label on DailyMed (published Sep 18, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.